Effects of HMOs on Faecal Microbiota, Gastrointestinal Symptoms, Mucosal Immunity and Barrier Function in IBS Patients

Clinical trial NCT02875847 · COMPLETED

Trial details

NCT number: NCT02875847
Sponsor: Glycom A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome (IBS)

Start date: 2016-09-01
Primary completion: 2018-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.